Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Simona I. Chisalita"'
Publikováno v:
Cardiovascular Diabetology, Vol 23, Iss 1, Pp 1-7 (2024)
Abstract Objectives There is currently limited understanding of the relationship between copeptin, the midregional portion of proadrenomedullin (MRproADM) and the midregional fragment of the N-terminal of proatrial natriuretic peptide (MRproANP), and
Externí odkaz:
https://doaj.org/article/64fe051f115145b0b09121e075d4bd8a
Autor:
Lee Ti Davidson, Ulf Martin Schilling, Hans J. Arnqvist, Fredrik H. Nystrom, Simona I. Chisalita
Publikováno v:
Upsala Journal of Medical Sciences, Vol 128, Pp 1-8 (2023)
Background: Predicting the risk of readmission or death in patients at the emergency department (ED) is essential in identifying patients who would benefit the most from interventions. We aimed to explore the prognostic value of mid-regional proadren
Externí odkaz:
https://doaj.org/article/59e254371b7c4bc68eb376ea3c2679ed
Autor:
Lee Ti Davidson, Emilia Gauffin, Preben Henanger, Maciej Wajda, Daniel Wilhelms, Bertil Ekman, Hans J. Arnqvist, Martin Schilling, Simona I. Chisalita
Publikováno v:
Upsala Journal of Medical Sciences, Vol 127, Pp 1-8 (2022)
Background: One of the most critical decisions that emergency department (ED) physicians make is the discharge versus admission of patients. We aimed to study the association of the decision in the ED to admit patients with chest pain and/or breathle
Externí odkaz:
https://doaj.org/article/bd2e016b48104f219703e8cce240ba63
Publikováno v:
Journal of Clinical Medicine, Vol 11, Iss 19, p 5510 (2022)
Growth hormone (GH) changes body composition, including increasing body water. GH is known to have an anti-natriuretic effect in the kidney, but little is known of its effect on arginine-vasopressin (AVP) release. We studied the effect of GH on AVP r
Externí odkaz:
https://doaj.org/article/27bfc8e1fdb14da3bbbced98616cf183
Autor:
Simona I. Chisalita, J. Ludvigsson
Publikováno v:
Journal of Diabetes Research, Vol 2018 (2018)
Background. Type 1 diabetes (T1D) in adolescents is associated with alterations in the insulin-like factor system probably caused both by a deranged metabolism and insulinopenia in the portal vein. Objective. To study how the circulating IGF-1 is aff
Externí odkaz:
https://doaj.org/article/82b815537611414dbd4f6c95f16cfe24
Publikováno v:
Journal of Clinical Medicine; Volume 11; Issue 19; Pages: 5510
Growth hormone (GH) changes body composition, including increasing body water. GH is known to have an anti-natriuretic effect in the kidney, but little is known of its effect on arginine-vasopressin (AVP) release. We studied the effect of GH on AVP r
Autor:
Anna Spångeus, Carl Johan Östgren, Lee Ti Davidson, Fredrik H. Nystrom, Magnus Wijkman, Simona I. Chisalita
Publikováno v:
Diabetes research and clinical practice. 161
Our aim was to analyze the predictive value of toe brachial index (TBI) as a risk marker for future major adverse cardiovascular events (MACE) and all-cause mortality in patients with type 2 diabetes (T2D).TBI was measured in 741 patients with T2D in
Autor:
Simona I. Chisalita, Lars Adolfsson, Lee Ti Chong, Anna Spångeus, Mischa Woisetschläger, Maciej Wajda
Publikováno v:
Orthopaedic Surgery. 9:380-385
OBJECTIVE Elderly patients suffer fractures through low-energy mechanisms. The distal radius is the most frequent fracture localization. Insulin-like growth factor-1 (IGF1) plays an important role in the maintenance of bone mass and its levels declin
Autor:
Nanne Kleefstra, Reinold O. B. Gans, Henk J. G. Bilo, Hans J. Arnqvist, Simona I. Chisalita, Klaas H. Groenier, Christina A. Hedman, Peter R van Dijk, Susan J. J. Logtenberg
Publikováno v:
Journal of Clinical Endocrinology and Metabolism, 101(6), 2493-2501. ENDOCRINE SOC
Context: In type 1 diabetes mellitus, low levels of insulin-like growth factor -1 (IGF-1) and IGF binding protein-3 (IGFBP-3) and high levels of GH and IGFBP-1 are present, probably due to portal vein insulinopenia.Objective: To test the hypothesis t
Autor:
Reinold O. B. Gans, Susan J. J. Logtenberg, Simona I. Chisalita, Klaas H. Groenier, Nanne Kleefstra, Henk J. G. Bilo, Hans J. Arnqvist, Christina A. Hedman, Peter R van Dijk
Publikováno v:
Growth hormone & igf research, 25(6), 316-319
Objective: Low concentrations of insulin-like growth factor-I (IGFI) have been reported in type 1 diabetes mellitus (T1DM), suggested to be due to low insulin concentrations in the portal vein. The aim was to describe the long-term course of IGFI con